Application of an AI-driven autonomous robotic platform to enable cost- effective, scalable, and infrastructure-agnostic manufacturing of cell and gene therapies
Conference Dates
February 1 – 5, 2026
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Rodney Rietze, "Application of an AI-driven autonomous robotic platform to enable cost- effective, scalable, and infrastructure-agnostic manufacturing of cell and gene therapies" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/49
18.pdf (95 kB)
COinS